Search
Patexia Research
Case number IPR2021-00816

Regeneron Pharmaceuticals, Inc. et al. v. Novartis Pharma AG et al. > Documents

Date Field Doc. No.PartyDescription
Jan 20, 2023 0 petitioner Download
Apr 16, 2021 1 petitioner PETITION FOR INTER PARTES REVIEW OF U.S. PATENT NO. 9,220,631 Download
Apr 16, 2021 2 petitioner POWER OF ATTORNEY FOR PETITIONER REGENERON PHARMACEUTICALS, INC. Download
Apr 28, 2021 3 board Notice of Accord Filing Date Download
May 7, 2021 4 patent_own Download
May 7, 2021 5 patent_own Patent Owner Novartis Pharma AG's Power of Attorney Download
May 7, 2021 6 patent_own Patent Owner Novartis Pharmaceutical Corporation's Power of Attorney Download
May 7, 2021 7 patent_own Patent Owner Novartis Technology LLC's Power of Attorney Download
Jul 28, 2021 8 patent_own Download
Jul 28, 2021 9 patent_own Download
Jul 28, 2021 10 patent_own Download
Aug 20, 2021 11 petitioner Petitioner's Reply to Patent Owner's Preliminary Response Download
Aug 27, 2021 12 patent_own Download
Oct 26, 2021 13 board Institution Decision: Grant Download
Oct 26, 2021 14 board Order: Scheduling Order Download
Oct 28, 2021 15 board ORDER Denying Patent Owners Motion to Seal 37 C.F.R. sec s 42.14 and 42.54 Download
Nov 9, 2021 16 petitioner Petitioner's Objections to Admissibility of Evidence Submitted by Patent Owner Download
Nov 9, 2021 17 patent_own Patent Owners Objections to Admissibility of Evidence Submitted by Petitioners Download
Nov 19, 2021 18 patent_own Patent Owners Second Motion to Seal Download
Nov 19, 2021 19 patent_own Patent Owners Updated Exhibit List Download
Nov 23, 2021 20 petitioner Petitioner's Notice of Supplemental Evidence Download
Nov 23, 2021 21 petitioner Petitioner's First Supplemental Exhibit List Download
Nov 30, 2021 22 board Order: Granting Patent Owner's Second Motion to Seal - 37 CFR 42.14 and 42.54 Download
Dec 2, 2021 23 patent_own Patent Owners' Notice of Deposition of Horst Koller Under C.F.R. Section 42.53 Download
Dec 3, 2021 24 petitioner Petitioner's Corrected First Supplemental Exhibit List Download
Dec 22, 2021 25 patent_own Patent Owners Motion for Pro Hac Vice Admission of Nicholas K. Mitrokostas Under 37 C.F.R. Section 42.10(c) Download
Dec 22, 2021 26 patent_own Patent Owners Updated Exhibit List Download
Dec 22, 2021 27 petitioner Motion: PHV Download
Dec 22, 2021 28 petitioner Notice: exhibit list Download
Dec 23, 2021 29 patent_own Patent Owners Notice of Deposition of Szilard Kiss Under C.F.R. Section 42.53 Download
Jan 5, 2022 30 board Order: Granting Patent Owner's Motion for Admission Pro Hac Vice of Nicholas K. Mitrokostas Download
Jan 5, 2022 31 board Order: Granting Petitioner's Motion for Admission Pro Hac Vice of Petra Scamborova Download
Jan 7, 2022 32 petitioner IPR2021-00816, Petitioner's Updated Mandatory Notices Download
Jan 18, 2022 33 petitioner IPR2021-00816, Petitioner's Updated Power of Attorney Download
Jan 18, 2022 34 petitioner 2022-01-18, Petitioner's Updated Exhibit List Download
Jan 18, 2022 36 patent_own Patent Owner's Contingent Motion to Amend Under 37 C.F.R. Section 42.121 [PUBLIC REDACTED VERSION] Download
Jan 18, 2022 38 patent_own Patent Owners' Third Motion to Seal and Motion for a Modified Default Protective Order Download
Jan 19, 2022 39 patent_own Patent Owner's Updated Exhibit List Download
Jan 19, 2022 40 patent_own Novartis Pharma AG, Novartis Technology LLC, and Novartis Pharmaceuticals Corporation's Patent Owner Response [PUBLIC REDACTED VERSION] Download
Jan 19, 2022 41 patent_own Joint Stipulation to Modify Due Dates 1 and 2 Download
Jan 25, 2022 42 petitioner IPR2021-00816, 2022-01-25, Updated Exhibit List Download
Jan 26, 2022 43 petitioner Download
Jan 26, 2022 44 petitioner IPR2021-00816, 2022-01-25, Motion for Pro Hac Vice - Robert Vlasis Download
Jan 27, 2022 45 board ORDER Granting Petitioners Motion for Pro Hac Vice Admission of Robert Vlasis 37 C.F.R. sec 42.10 Download
Feb 15, 2022 46 petitioner Petitioner's Updated Power of Attorney Download
Feb 15, 2022 47 petitioner Petitioner's Updated Mandatory Notices Download
Mar 2, 2022 48 petitioner IPR2021-00816 Deposition Notice of Kimberly Cameron Download
Mar 2, 2022 49 petitioner IPR2021-00816 Deposition Notice of Juergen Sigg Download
Mar 2, 2022 50 petitioner IPR2021-00816 Deposition Notice of Marie Picci Download
Mar 2, 2022 51 petitioner IPR2021-00816 Deposition Notice of Karl Leinsing Download
Mar 2, 2022 52 petitioner IPR2021-00816 Deposition Notice of Michael Miller Download
Mar 2, 2022 53 petitioner Deposition Notice of Andrew F. Calman Download
Mar 2, 2022 54 petitioner Deposition Notice of John Dillberger Download
Mar 2, 2022 55 petitioner Deposition Notice of James Malackowski Download
Mar 2, 2022 56 petitioner Deposition Notice of Jeremy Wolfe Download
Mar 3, 2022 57 board Panel Change Order Download
Mar 3, 2022 58 patent_own Patent Owner Novartis Pharma AG's Updated Power of Attorney Download
Mar 3, 2022 59 patent_own Patent Owner Novartis Pharmaceuticals Corporation's Updated Power of Attorney Download
Mar 3, 2022 60 patent_own Patent Owner Novartis Technology LLC's Updated Power of Attorney Download
Mar 3, 2022 61 patent_own Patent Owners' Updated Mandatory Notices Download
Mar 3, 2022 62 patent_own Joint Motion for the Appointment of Commissioners and Direction of Submission of Hague Convention Application Download
Mar 3, 2022 63 patent_own Patent Owners' Updated Exhibit List Download
Mar 7, 2022 64 petitioner 2022-03-07 - Petitioner's Updated Mandatory Notices Download
Mar 8, 2022 65 board Order: Appointing Commissioners and Direction of Submission Download
Mar 24, 2022 66 patent_own Download
Mar 24, 2022 67 patent_own Patent Owners Updated Exhibit List Download
Mar 30, 2022 68 petitioner Petitioner's Updated Mandatory Notices Pursuant to 37 C.F.R. 42.8 Download
Apr 5, 2022 69 board Download
Apr 8, 2022 70 patent_own Joint Stipulation to Modify Due Dates 2 and 3 Download
Apr 15, 2022 71 petitioner Petitioner's Motion to Seal Download
Apr 15, 2022 73 petitioner Petitioner's Reply to Patent Owner's Response Download
Apr 15, 2022 75 petitioner Petitioner's Opposition to Patent Owner's Contingent Motion to Amend Download
Apr 22, 2022 76 patent_own Patent Owners' Objections To Admissibility of Evidence Submitted by Petitioner Download
May 3, 2022 77 patent_own Patent Owners' Notice of Deposition of James Agalloco Under 37 C.F.R. Section 42.53 Download
May 3, 2022 78 patent_own Patent Owners' Notice of Deposition of Szilard Kiss Under 37 C.F.R. Section 42.53 Download
May 4, 2022 79 patent_own Patent Owners' Notice of Deposition of Horst Koller Under 37 C.F.R. Section 42.53 Download
May 4, 2022 80 patent_own Patent Owners' Notice of Deposition of Joel M. Cohen Under 37 C.F.R. Section 42.53 Download
May 4, 2022 81 patent_own Patent Owners' Notice of Deposition of Kenneth S. Graham Under 37 C.F.R. Section 42.53 Download
May 4, 2022 82 patent_own Patent Owners' Notice of Deposition of Lisa Cameron Under 37 C.F.R. Section 42.53 Download
May 4, 2022 83 patent_own Patent Owners' Notice of Deposition of W. Gregory Sawyer Under 37 C.F.R. Section 42.53 Download
May 6, 2022 84 petitioner Petitioner's Updated Exhibit List Download
May 11, 2022 85 patent_own Patent Owners' Fourth Motion to Seal Download
May 11, 2022 86 patent_own Patent Owners' Updated Exhibit List Download
May 25, 2022 88 board Order: Other Download
May 26, 2022 89 patent_own Patent Owner's Notice of Withdrawal of Its Contingent Motion to Amend Download
May 26, 2022 90 patent_own Patent Owner's Fifth Motion to Seal Download
May 26, 2022 91 patent_own Patent Owner's Updated Exhibit List Download
May 26, 2022 93 patent_own Patent Owner's Surreply to Petitioner's Reply - REDACTED Download
May 27, 2022 94 patent_own Notice of Certification of Word Count for Patent Owners' Surreply to Petitioner's Reply Download
Jun 3, 2022 95 petitioner PETITIONER'S THIRD OBJECTIONS TO ADMISSIBILITY OF EVIDENCE SUBMITTED BY PATENT OWNER Download
Jun 6, 2022 96 petitioner Download
Jun 14, 2022 97 petitioner Petitioners Request For Oral Argument Download
Jun 14, 2022 98 patent_own Patent Owner's Request for Oral Argument Download
Jun 27, 2022 99 board Download
Jun 30, 2022 100 board Preliminary Guidance Patent Owner's Motion to Amend (PUBLIC VERSION) Download
Jul 5, 2022 101 patent_own Patent Owner's Motion to Exclude Evidence Download
Jul 6, 2022 102 patent_own Joint Notice to Modify Date to Serve Demonstratives on Opposing Counsel Download
Jul 8, 2022 103 board Order: Granting Patent Owner's Third, Fourth, and Fifth Motions to Seal - Granting Patent Owner's Motion for Entry of Second Modified Default Protective Order - 37 CFR 42.14 and 42.54 Download
Jul 12, 2022 104 petitioner Petitioner's Opposition to Patent Owner's Motion to Exclude Download
Jul 13, 2022 105 board Download
Jul 13, 2022 106 patent_own Patent Owner's Second Updated Mandatory Notices Download
Jul 13, 2022 107 patent_own Patent Owner's Updated Power of Attorney (Novartis Pharma AG) Download
Jul 13, 2022 108 patent_own Patent Owner's Updated Power of Attorney (Novartis Pharmaceuticals Corporation) Download
Jul 13, 2022 109 patent_own Patent Owner's Updated Power of Attorney (Novartis Technology Corporation) Download
Jul 18, 2022 110 patent_own Download
Aug 12, 2022 111 petitioner Joint Motion to Expunge Download
Sep 6, 2022 112 board Other: Hearing transcript Download
Oct 25, 2022 114 board Order: Dismissing Motion to Exclude as Moot 37 C.F.R. secs. 42.64c, 42.61a Download
Nov 1, 2022 115 board Order: Directing the Submission of a Redacted Public Version of the Final Written Decision and Granting the Joint Motion to Expunge Certain Exhibits - 37 CFR 42.5 and 42.14 Download
Dec 23, 2022 116 patent_own Patent Owner's Notice of Appeal Download
Jan 20, 2023 117 petitioner Joint Motion to Seal the Final Written Decision Download
Jan 24, 2023 119 board Final Written Decision: original Download
Jan 24, 2023 120 board Order: Order: Granting Joint Motion to Seal Download
Apr 16, 2021 1001 petitioner Download
Apr 16, 2021 1002 petitioner Prosecution File History of U.S. Patent No. 9,220,631, part 3 Download
Apr 16, 2021 1002 petitioner Prosecution File History of U.S. Patent No. 9,220,631, part 4 Download
Apr 16, 2021 1002 petitioner Prosecution File History of U.S. Patent No. 9,220,631, part 1 Download
Apr 16, 2021 1002 petitioner Prosecution File History of U.S. Patent No. 9,220,631, part 2 Download
Apr 16, 2021 1003 petitioner Download
Apr 16, 2021 1004 petitioner Curriculum Vitae of Horst Koller Download
Apr 16, 2021 1005 petitioner Download
Apr 16, 2021 1006 petitioner Download
Apr 16, 2021 1007 petitioner Download
Apr 16, 2021 1008 petitioner Download
Apr 16, 2021 1009 petitioner Internet Archive WayBack Machine, March 7, 2011 Record of Drugs.com, Macugen Prescribing Information Download
Apr 16, 2021 1010 petitioner ITC Investigation No. 337-TA-1207, Initial Determination Terminating the Investigation Download
Apr 16, 2021 1011 petitioner Download
Apr 16, 2021 1012 petitioner Download
Apr 16, 2021 1013 petitioner Download
Apr 16, 2021 1014 petitioner Download
Apr 16, 2021 1015 petitioner Download
Apr 16, 2021 1015 petitioner Download
Apr 16, 2021 1015 petitioner Download
Apr 16, 2021 1015 petitioner Download
Apr 16, 2021 1016 petitioner Download
Apr 16, 2021 1016 petitioner Download
Apr 16, 2021 1016 petitioner Download
Apr 16, 2021 1016 petitioner Download
Apr 16, 2021 1017 petitioner Download
Apr 16, 2021 1018 petitioner Download
Apr 16, 2021 1019 petitioner U.S. Pharmacopeia, USP 789, Particulate Matter in Ophthalmic Solutions, USP 34 NF 29 (2011) Download
Apr 16, 2021 1020 petitioner Download
Apr 16, 2021 1021 petitioner Download
Apr 16, 2021 1022 petitioner Download
Apr 16, 2021 1023 petitioner Download
Apr 16, 2021 1024 petitioner Download
Apr 16, 2021 1025 petitioner Download
Apr 16, 2021 1026 petitioner Download
Apr 16, 2021 1027 petitioner Download
Apr 16, 2021 1028 petitioner Download
Apr 16, 2021 1029 petitioner Download
Apr 16, 2021 1030 petitioner Download
Apr 16, 2021 1031 petitioner Download
Apr 16, 2021 1032 petitioner Curriculum Vitae of Dr. Szilard Kiss Download
Apr 16, 2021 1033 petitioner Declaration of James L. Mullins, Ph.D. Download
Apr 16, 2021 1034 petitioner Download
Apr 16, 2021 1035 petitioner European Patent Application No. 12174860 to Novartis AG Download
Apr 16, 2021 1036 petitioner Download
Apr 16, 2021 1037 petitioner Affidavit of Internet Archive Office Manager Download
Apr 16, 2021 1038 petitioner Internet Archive WayBack Machine, March 8, 2011 Record of Drugs.com, Welcome to Drugs.com Download
Apr 16, 2021 1039 petitioner Internet Archive WayBack Machine, February 25, 2011 Record of Drugs.com, FDA Professional Drug Information Download
Apr 16, 2021 1040 petitioner Download
Apr 16, 2021 1041 petitioner Download
Apr 16, 2021 1042 petitioner Download
Apr 16, 2021 1043 petitioner Download
Apr 16, 2021 1044 petitioner Download
Apr 16, 2021 1045 petitioner Download
Apr 16, 2021 1046 petitioner Download
Apr 16, 2021 1047 petitioner Download
Apr 16, 2021 1048 petitioner Download
Apr 16, 2021 1049 petitioner Download
Apr 16, 2021 1050 petitioner Download
Apr 16, 2021 1051 petitioner Download
Apr 16, 2021 1052 petitioner Download
Apr 16, 2021 1053 petitioner FDA Pesticide Analytical Manual Vol. 1, Chapter 6 - HPLC Download
Apr 16, 2021 1054 petitioner Download
Apr 16, 2021 1055 petitioner Download
Apr 16, 2021 1056 petitioner Download
Apr 16, 2021 1057 petitioner Download
Apr 16, 2021 1058 petitioner Christine I. Falkner-Radler, et al. Needle Size in Intravitreal Injections-Preliminary Results of a Randomized Clinical Trial, AVRO Annual Meeting Abstract, March 2012, 54(884) Download
Apr 16, 2021 1059 petitioner Download
Apr 16, 2021 1060 petitioner Curriculum Vitae of James L. Mullins, Ph.D. Download
Apr 16, 2021 1061 petitioner Download
Apr 16, 2021 1062 petitioner Download
Apr 16, 2021 1063 petitioner Evangelos S. Gragoudas, et al. Pegaptanib for Neovascular Age-Related Macular Degeneration, New England Journal of Medicine 2004; 351:2805-16, with Supplementary Appendix. Download
Apr 16, 2021 1064 petitioner IPR2020-1317, Paper No. 15, Institution Decision Download
Apr 16, 2021 1065 petitioner Anita M. Leys, et al. Neovascular Growth Following Photodynamic Therapy for Choroidal Hemangioma and Neovascular Regression after Intravitreous Injection of Triamcinolone, Retina 2006; 26(6):693-7 Download
Apr 16, 2021 1066 petitioner Australian Government, Department of Health and Ageing, Australian Public Assessment Report for Aflibercept, (July 2012), part 1 Download
Apr 16, 2021 1066 petitioner Australian Government, Department of Health and Ageing, Australian Public Assessment Report for Aflibercept, (July 2012), part 2 Download
Apr 16, 2021 1067 petitioner Sophie J. Bakri and Noha S. Ekdawi, Intravitreal Silicone Oil Droplets after Intravitreal Drug Injections, Retina 2008; 20:996-1001 Download
Apr 16, 2021 1068 petitioner Jared S. Bee, et al. Effects of Surfaces and Leachables on the Stability of Biopharmaceuticals, Journal of Pharmaceutical Science (Oct. 2011) Download
Apr 16, 2021 1069 petitioner Michael Colucciello, Prefilled Syringe Delivery of Intravitreal Anti-VEGF Medications: Advantages for Patients and Physicians, Retinal Physician (Mar. 1, 2019) Download
Apr 16, 2021 1070 petitioner Download
Apr 16, 2021 1071 petitioner Department of Health & Human Services, Macugen Approval Letter (Dec. 18, 2004) Download
Apr 16, 2021 1072 petitioner Lonny Wolgemuth, Challenges with Prefilled Syringes: The Parylene Solution, ONdrugDelivery (Oct. 2012) Download
Apr 16, 2021 1073 petitioner Therese M. Sassalos, Prefilled Syringes for Intravitreal Drug Delivery, Clinical Ophthalmology 2019:13 701-706 Download
Apr 16, 2021 1074 petitioner SCS Coating Systems, SCS Parylene Properties (2007) Download
Apr 16, 2021 1075 petitioner Lonny Wolgemuth, Assessing the Effects of Sterilization Methods on Parylene Coating, Medical Device & Diagnostic Industry, (Aug. 2002) Download
Apr 16, 2021 1076 petitioner Download
Apr 16, 2021 1077 petitioner SDNY 20-5502 Docket Download
Apr 16, 2021 1078 petitioner Federal Court Statistics Download
Apr 16, 2021 1079 petitioner Novartis Letter to NDNY Court Download
Apr 16, 2021 1080 petitioner Mehmet S. Kocabora, et al. Intravitreal Silicone Oil Droplets Following Pegaptanib Injection, Acta Ophthalmologica 2010 Download
Apr 16, 2021 1081 petitioner Macugen Label (2008) Download
Apr 16, 2021 1082 petitioner U.S. Pharmacopeia, USP 789, Particulate Matter in Ophthalmic Solutions, USP 32 NF 27 (2009) Download
Apr 16, 2021 1083 petitioner Novartis NDNY Complaint Download
Apr 16, 2021 1084 petitioner Novartis Letter to SDNY Court Download
Apr 16, 2021 1085 petitioner ITC Investigation No. 337-TA-1207, Statement on the Public Interest by Proposed Respondent Regeneron Pharmaceuticals, Inc. Download
Apr 16, 2021 1086 petitioner ITC Investigation No. 337-TA-1207, Statement on the Public Interest by Szilard Kiss Download
Apr 16, 2021 1087 petitioner Download
Apr 16, 2021 1088 petitioner PCT Patent Publication No. WO 2007/084765 to Deschatelets et al. Download
Apr 16, 2021 1089 petitioner PCT Patent Publication No. WO 97/44068 to Tack et al. Download
Aug 20, 2021 1090 petitioner Text Minute Entry re Rule 16 Conference held on August 18, 2021, Novartis Pharma AG et al v. Regeneron Pharma., Inc., No. 1:20-cv-00690 (N.D.N.Y. Aug. 18, 2021) Download
Nov 23, 2021 1091 petitioner Declaration of Juergen Sigg Download
Nov 23, 2021 1092 petitioner Download
Nov 23, 2021 1093 petitioner Download
Nov 23, 2021 1094 petitioner ONDrugDelivery, Prefilled Syringe, available at https://ondrugdelivery.com/magazines/prefilled-syringes-the-rise-of-the-delivery-device-portfolio/ Download
Dec 22, 2021 1095 petitioner Declaration of Petra Scamborova Download
Dec 22, 2021 1096 petitioner P. Scamborova LinkedIn Profile Download
Jan 18, 2022 1097 petitioner Ex. 1097, 2022-01-06 Telephonic Conference Download
Jan 25, 2022 1098 petitioner Ex. 1098, Declaration of Robert T. Vlasis ISO Motion for Pro Hac Vice Download
Jan 25, 2022 1099 petitioner Ex. 1099, Bio for Robert T. Vlasis - Weil Gotshal Manges Download
Apr 15, 2022 1100 petitioner Declaration of James Agalloco Download
Apr 15, 2022 1101 petitioner Declaration of Dr. Gregory Sawyer Download
Apr 15, 2022 1102 petitioner Declaration of Dr. Kenneth Graham Download
Apr 15, 2022 1103 petitioner Second Declaration of James L. Mullins, Ph.D. Download
Apr 15, 2022 1105 petitioner Reply Declaration of Horst Koller Download
Apr 15, 2022 1106 petitioner Reply Declaration of Dr. Szilard Kiss Download
Apr 15, 2022 1107 petitioner Declaration of Lisa Cameron Download
Apr 15, 2022 1108 petitioner Declaration of Joel M. Cohen Download
Apr 15, 2022 1109 petitioner Deposition of Kim Cameron, Ph.D., (3/17/2022) Download
Apr 15, 2022 1110 petitioner Persson, et. al., Elastic contact mechanics: Percolation of the contact area and fluid squeeze-out, Eur. Phys. J. E. (2012) Download
Apr 15, 2022 1111 petitioner Nishimoto, et al., Determination of Conditions for the Production Scale Sterilization of Prefilled Syringes, 57 PDA J Pharm Sci. & Tech, 378-386 (2003) Download
Apr 15, 2022 1115 petitioner Download
Apr 15, 2022 1129 petitioner Download
Apr 15, 2022 1163 petitioner REGITC00138524 - Requirements on pre-fillable glass syringes Download
Apr 15, 2022 1164 petitioner Optical in Situ Micro Tribometer for Analysis of Real Contact Area for Contact Mechanics, Adhesion, and Sliding Experiments, B. A. Krick, J. R. Vail, B. N. J. Persson, and W. G. Sawyer, Tribology Letters 45 (2012) 185-194 Download
Apr 15, 2022 1165 petitioner Plasmonic Diagnostics for Tribology: In Situ Observations using Surface Plasmon Resonance in Combination with Surface-Enhanced Raman Spectroscopy, B. A. Krick, D. H. Hahn, and W. G. Sawyer, Tribology Letters, 49 (2013) 95-102. Download
Apr 15, 2022 1166 petitioner Accessing Inaccessible Interfaces: In Situ Approaches to Materials Tribology, W. G. Sawyer & K. J. Wahl, Guest Editors MRS Bulletin 33 (2008) 1145-1189 Download
Apr 15, 2022 1169 petitioner Lorenz, et al., Static or breakloose friction for lubricated contacts: the role of surface roughness and dewetting, J. Phys. Condens. Matter 25 (2013) Download
Apr 15, 2022 1170 petitioner Curriculum Vitae of Lisa Cameron Download
Apr 15, 2022 1171 petitioner Download
Apr 15, 2022 1172 petitioner Deposition of James E. Malackowski, IPR2021-00816 (3/29/2022) Download
Apr 15, 2022 1173 petitioner Jesse David and Marion Stewart, Commercial Success: Economic Principles Applied to Patent Litigation Download
Apr 15, 2022 1174 petitioner Download
Apr 15, 2022 1175 petitioner Download
Apr 15, 2022 1176 petitioner Download
Apr 15, 2022 1177 petitioner Download
Apr 15, 2022 1178 petitioner Novartis Ophthalmics and Genentech announce development and commercialization agreement for age-related macular degeneration treatment, Lucentis(TM), Novartis Pharma AG press release, June 25, 2003 Download
Apr 15, 2022 1179 petitioner Bayer HealthCare AG And Regeneron Pharmaceuticals, Inc. To Collaborate On VEGF Trap For The Treatment Of Eye Diseases Regeneron Retains U.S. Commercialization Rights, Receives $75 Million Upfront, October 19, 2006 Download
Apr 15, 2022 1180 petitioner Download
Apr 15, 2022 1181 petitioner Beovu (brolucizumab injection) now publicly reimbursed in Ontario and New Brunswick for the treatment of neovascular (wet) age-related macular degeneration, Yahoo Finance, December 16, 2021 Download
Apr 15, 2022 1182 petitioner Mali Okada et al., Nonadherence or Nonpersistence to Intravitreal Injection Therapy for Neovascular Age-Related Macular Degeneration: A Mixed Methods Systematic Review, Ophthalmology 128(2):234-247, August 5, 2020 Download
Apr 15, 2022 1183 petitioner Download
Apr 15, 2022 1184 petitioner Turbert, What is Avastin?, American Academy of Ophthalmology, April 23, 2021 Download
Apr 15, 2022 1186 petitioner Highlights of Prescribing Information, Avastin, FDA, revised December 2020 Download
Apr 15, 2022 1187 petitioner Callan Navitsky, The Regulation of Compounding Pharmacies, Retina Today, November/December 2012 Download
Apr 15, 2022 1188 petitioner Highlights of Prescribing Information, Beovu, revised March, 2022 Download
Apr 15, 2022 1189 petitioner Download
Apr 15, 2022 1190 petitioner Angus Liu, Novartis calls off 3 Beovu trials testing more frequent dosing on concerns of vision-threatening side effect, FiercePharma, June 1, 2021 Download
Apr 15, 2022 1191 petitioner Highlights of Prescribing Information, Macugen, revised July 2011 Download
Apr 15, 2022 1192 petitioner Highlights of Prescribing Information, Susvimo, revised October 2021, Download
Apr 15, 2022 1193 petitioner Susvimo 10 Mg/0.1Ml Implant Solution Macular Degeneration Treatment Agents-VEGF Antagonist Type- Uses, Side Effects, and More, WebMD Download
Apr 15, 2022 1194 petitioner Download
Apr 15, 2022 1195 petitioner Download
Apr 15, 2022 1196 petitioner Highlights of Prescribing Information, Vabysmo, revised January 2022, Download
Apr 15, 2022 1197 petitioner Jarosz and Vigil International In-house Counsel Journal Summer 2015 Assessing Commercial Success at the U.S. Patent Trial and Appeal Board Download
Apr 15, 2022 1198 petitioner Download
Apr 15, 2022 1199 petitioner Excerpt of Wooldridge, Jeffrey M., Econometric Analysis of Cross Section and Panel Data, MIT Press Download
Apr 15, 2022 1200 petitioner Highlights of Prescribing Information, Lucentis, FDA, revised October 2016 Download
Apr 15, 2022 1201 petitioner Highlights of Prescribing Information, Lucentis, FDA, revised January 2017 Download
Apr 15, 2022 1202 petitioner Highlights of Prescribing Information, Lucentis, FDA, revised August 2012 Download
Apr 15, 2022 1204 petitioner Our Services, Vetter, accessed February 24, 2022 Download
Apr 15, 2022 1208 petitioner Deposition of Andrew F. Calman, IPR2021-00816 Download
Apr 15, 2022 1209 petitioner Deposition of John Dillberger, IPR2021-00816 Download
Apr 15, 2022 1210 petitioner Deposition of Michael J. Miller, IPR2021-00816 Download
Apr 15, 2022 1212 petitioner Deposition of Jeremy Wolfe, IPR2021-00816 (3/19/2022) Download
Apr 15, 2022 1214 petitioner Kinney, Delivering Therapeutic siRNA, Drug Delivery Technology, Vol. 9, No. 2 (Feb. 2009) Download
Apr 15, 2022 1227 petitioner REG_NDNY_00000004 - Gilead Sciences Inc. Form 10-K (3/6) Download
Apr 15, 2022 1227 petitioner REG_NDNY_00000004 - Gilead Sciences Inc. Form 10-K (1/6) Download
Apr 15, 2022 1227 petitioner REG_NDNY_00000004 - Gilead Sciences Inc. Form 10-K (6/6) Download
Apr 15, 2022 1227 petitioner REG_NDNY_00000004 - Gilead Sciences Inc. Form 10-K (4/6) Download
Apr 15, 2022 1227 petitioner REG_NDNY_00000004 - Gilead Sciences Inc. Form 10-K (5/6) Download
Apr 15, 2022 1227 petitioner REG_NDNY_00000004 - Gilead Sciences Inc. Form 10-K (2/6) Download
Apr 15, 2022 1229 petitioner Lambert, Rationale for practical medical device accelerated aging programs in AAMI TIR 17, Radiation Physics and Chemistry, 57 (2000) 349-353 Download
Apr 15, 2022 1230 petitioner Standard Guide for Accelerated Aging of Sterile Medical Device Packages, Designation: F-1980-02 Download
Apr 15, 2022 1231 petitioner Center for Drug Evaluation and Research, Application No. NDA 22-220, Trivaris Download
Apr 15, 2022 1232 petitioner Internet Archive WayBack Machine, Eyetech, Inc.: Science, Vision, Hope Download
Apr 15, 2022 1233 petitioner Download
Apr 15, 2022 1234 petitioner Download
Apr 15, 2022 1235 petitioner Download
Apr 15, 2022 1236 petitioner Download
Apr 15, 2022 1237 petitioner Download
Apr 15, 2022 1238 petitioner Download
Apr 15, 2022 1239 petitioner Download
Apr 15, 2022 1240 petitioner Download
Apr 15, 2022 1241 petitioner Download
Apr 15, 2022 1242 petitioner R. DeForest McDuff, Ryan C. Andrews, and Matt D. Brundage, Thinking Economically about Commercial Success, Landslide, 9(4): 1-5 (Mar./Apr. 2017) Download
Apr 15, 2022 1243 petitioner Kevin L. Varghese, No Need to Neglect Nexus: Prosecution Lessons from FOX Factory v. SRAM, Intellectual Property & Tech. Law J., 32(6): 16 (June 2020) Download
Apr 15, 2022 1244 petitioner Ernst R. Berndt et al., Information, Marketing, and Pricing in the U.S. Antiulcer Drug Market, The American Economic Review 85(2): 102-103 (1995) Download
Apr 15, 2022 1245 petitioner Excerpt of Opening Report of Szilard Kiss, M.D., ITC Inv. No. 337-TA-1207 (Jan. 22, 2021) Download
Apr 15, 2022 1246 petitioner GlobalData Healthcare, The dominance of Eylea is expected to persist in the foreseeable future, Pharma Tech., July 1, 2020 (updated Dec. 1, 2021) Download
Apr 15, 2022 1247 petitioner Helen Marshall, Eylea (aflibercept), Medical News Today, February 16, 2020 Download
Apr 15, 2022 1250 petitioner REGITC00376214 - Novartis Completes Safety Review and Initiates Update to the Beovu Information Worldwide Download
Apr 15, 2022 1251 petitioner Download
Apr 15, 2022 1252 petitioner Application No. 13382380 File History Excerpts Download
Apr 15, 2022 1253 petitioner Download
Jan 20, 2023 1257 petitioner Redacted Final Written Decision Download
Jul 28, 2021 2001 patent_own Declaration of Karl R. Leinsing, PE Download
Jul 28, 2021 2002 patent_own Declaration of Marie Picci [Public Redacted Version] Download
Jul 28, 2021 2003 patent_own 2003 Download
Jul 28, 2021 2004 patent_own 2004 Download
Jul 28, 2021 2005 patent_own 2005 Download
Jul 28, 2021 2006 patent_own 2006 Download
Jul 28, 2021 2007 patent_own 2007 Download
Jul 28, 2021 2008 patent_own 2008 Download
Jul 28, 2021 2009 patent_own 2009 Download
Jul 28, 2021 2010 patent_own 2010 Download
Jul 28, 2021 2011 patent_own 2011 Download
Jul 28, 2021 2012 patent_own 2012 Download
Jul 28, 2021 2013 patent_own 2013 Download
Jul 28, 2021 2014 patent_own 2014 Download
Jul 28, 2021 2015 patent_own 2015 Download
Jul 28, 2021 2016 patent_own 2016 Download
Jul 28, 2021 2017 patent_own 2017 Download
Jul 28, 2021 2018 patent_own 2018 Download
Jul 28, 2021 2019 patent_own 2019 Download
Jul 28, 2021 2020 patent_own 2020 Download
Jul 28, 2021 2021 patent_own 2021 Download
Jul 28, 2021 2022 patent_own 2022 Download
Jul 28, 2021 2023 patent_own 2023 Download
Jul 28, 2021 2024 patent_own 2024 Download
Jul 28, 2021 2025 patent_own 2025 Download
Jul 28, 2021 2026 patent_own 2026 Download
Jul 28, 2021 2027 patent_own 2027 Download
Jul 28, 2021 2028 patent_own 2028 Download
Jul 28, 2021 2029 patent_own 2029 Download
Jul 28, 2021 2030 patent_own 2030 Download
Jul 28, 2021 2031 patent_own 2031 Download
Jul 28, 2021 2032 patent_own 2032 Download
Jul 28, 2021 2033 patent_own 2033 Download
Jul 28, 2021 2034 patent_own 2034 Download
Jul 28, 2021 2035 patent_own 2035 Download
Jul 28, 2021 2036 patent_own 2036 Download
Jul 28, 2021 2041 patent_own 2041 Download
Jul 28, 2021 2042 patent_own 2042 Download
Jul 28, 2021 2044 patent_own 2044 Download
Jul 28, 2021 2045 patent_own 2045 Download
Jul 28, 2021 2046 patent_own 2046 Download
Jul 28, 2021 2047 patent_own 2047 Download
Jul 28, 2021 2048 patent_own 2048 Download
Jul 28, 2021 2049 patent_own 2049 Download
Jul 28, 2021 2050 patent_own 2050 Download
Jul 28, 2021 2051 patent_own 2051 Download
Jul 28, 2021 2052 patent_own 2052 Download
Jul 28, 2021 2053 patent_own 2053 Download
Jul 28, 2021 2054 patent_own 2054 Download
Jul 28, 2021 2055 patent_own 2055 Download
Jul 28, 2021 2056 patent_own 2056 Download
Jul 28, 2021 2057 patent_own 2057 Download
Jul 28, 2021 2058 patent_own 2058 Download
Jul 28, 2021 2059 patent_own 2059 Download
Jul 28, 2021 2060 patent_own 2060 Download
Jul 28, 2021 2061 patent_own 2061 Download
Jul 28, 2021 2062 patent_own Declaration of Jeffrey Salling Download
Jan 18, 2022 2062 patent_own Ex. 2062 - Jeffrey Salling Declaration Download
Nov 19, 2021 2063 patent_own Exhibit 2063 [PUBLIC REDACTED VERSION] Download
Nov 19, 2021 2064 patent_own Exhibit 2064 [PUBLIC REDACTED VERSION] Download
Jul 28, 2021 2065 patent_own 2065 Download
Nov 19, 2021 2066 patent_own Exhibit 2066 [PUBLIC REDACTED VERSION] Download
Nov 19, 2021 2067 patent_own Exhibit 2067 [PUBLIC REDACTED VERSION] Download
Nov 19, 2021 2068 patent_own Exhibit 2068 [PUBLIC REDACTED VERSION] Download
Nov 19, 2021 2069 patent_own Exhibit 2069 [PUBLIC REDACTED VERSION] Download
Nov 19, 2021 2070 patent_own Exhibit 2070 [PUBLIC REDACTED VERSION] Download
Nov 19, 2021 2071 patent_own Exhibit 2071 [PUBLIC REDACTED VERSION] Download
Nov 19, 2021 2072 patent_own Exhibit 2072 [PUBLIC REDACTED VERSION] Download
Nov 19, 2021 2073 patent_own Exhibit 2073 [PUBLIC REDACTED VERSION] Download
Nov 19, 2021 2074 patent_own Exhibit 2074 [PUBLIC REDACTED VERSION] Download
Nov 19, 2021 2075 patent_own Exhibit 2075 [PUBLIC REDACTED VERSION] Download
Nov 19, 2021 2076 patent_own Exhibit 2076 [PUBLIC REDACTED VERSION] Download
Nov 19, 2021 2077 patent_own Exhibit 2077 [PUBLIC REDACTED VERSION] Download
Nov 19, 2021 2078 patent_own Exhibit 2078 [PUBLIC REDACTED VERSION] Download
Nov 19, 2021 2079 patent_own Exhibit 2079 [PUBLIC REDACTED VERSION] Download
Nov 19, 2021 2080 patent_own Exhibit 2080 [PUBLIC REDACTED VERSION] Download
Nov 19, 2021 2081 patent_own Exhibit 2081 [PUBLIC REDACTED VERSION] Download
Nov 19, 2021 2082 patent_own Exhibit 2082 [PUBLIC REDACTED VERSION] Download
Nov 19, 2021 2083 patent_own Exhibit 2083 [PUBLIC REDACTED VERSION] Download
Nov 19, 2021 2084 patent_own Exhibit 2084 [PUBLIC REDACTED VERSION] Download
Nov 19, 2021 2085 patent_own Exhibit 2085 [PUBLIC REDACTED VERSION] Download
Nov 19, 2021 2086 patent_own Exhibit 2086 [PUBLIC REDACTED VERSION] Download
Nov 19, 2021 2087 patent_own Exhibit 2087 [PUBLIC REDACTED VERSION] Download
Nov 19, 2021 2088 patent_own Exhibit 2088 [PUBLIC REDACTED VERSION] Download
Jul 28, 2021 2089 patent_own 2089 Download
Jul 28, 2021 2090 patent_own 2090 Download
Jul 28, 2021 2091 patent_own 2091 Download
Jul 28, 2021 2092 patent_own 2092 Download
Aug 27, 2021 2093 patent_own Exhibit 2093 Download
Aug 27, 2021 2094 patent_own Exhibit 2094 Download
Aug 27, 2021 2095 patent_own Exhibit 2095 Download
Aug 27, 2021 2096 patent_own Exhibit 2096 Download
Nov 19, 2021 2097 patent_own Download
Dec 22, 2021 2098 patent_own Exhibit 2098 - Declaration of Nicholas K. Mitrokostas in Support of Patent Owners Motion for Pro Hac Vice Admission of Nicholas K. Mitrokostas Under 37 C.F.R. Section 42.10(c) Download
Jan 18, 2022 2116 patent_own Ex. 2116 - Genentech Press Release Download
Jan 18, 2022 2117 patent_own Ex. 2117 - Genentech Press Release Download
Jan 19, 2022 2118 patent_own Ex. 2118 - NOVITC(CH)00002720 [Public Redacted Version] Download
Jan 19, 2022 2119 patent_own Ex. 2119 - NOVITC(CH)00003455 [PUBLIC REDACTED VERSION] Download
Jan 19, 2022 2120 patent_own Ex. 2120 - NOVITC(CH)00004818 [Public Redacted Version - Replacement] Download
Jan 19, 2022 2121 patent_own Ex. 2121 - NOVITC(CH)00005765 [Public Redacted Version] Download
Jan 19, 2022 2123 patent_own Ex. 2123 - NOVITC(CH)00007283 [Public Redacted Version] Download
Jan 19, 2022 2124 patent_own Ex. 2124 - NOVITC(CH)00008409 [Public Redacted Version] Download
Jan 18, 2022 2125 patent_own Ex. 2125 - Lucentis Prescribing Information Download
Jan 19, 2022 2125 patent_own Ex. 2125 - Lucentis Prescribing Information, revised March 2018 Download
Jan 18, 2022 2125 patent_own Ex. 2125 - Lucentis Prescribing Information, revised March 2018 Download
Jan 19, 2022 2126 patent_own Ex. 2126 - NOVITC(CH)00054063 [Public Redacted Version] Download
Jan 19, 2022 2128 patent_own Ex. 2128 - NOVITC(CH)00167663 [PUBLIC REDACTED VERSION] Download
Jan 19, 2022 2129 patent_own Ex. 2129 - NOVITC(CH)00168961 [Public Redacted Version] Download
Jan 19, 2022 2130 patent_own Ex. 2130 - NOVITC(CH)00169036 [PUBLIC REDACTED VERSION] Download
Jan 19, 2022 2131 patent_own Ex. 2131 - NOVITC(CH)00170304 [Public Redacted Version] Download
Jan 19, 2022 2133 patent_own Ex. 2133 - NOVITC(CH)00170896 [Public Redacted Version] Download
Jan 19, 2022 2134 patent_own Ex. 2134 - NOVITC(CH)00170915 [Public Redacted Version] Download
Jan 19, 2022 2136 patent_own Ex. 2136 - NOVITC(CH)00217349 [Public Redacted Version] Download
Jan 19, 2022 2137 patent_own Ex. 2137 - NOVITC(CH)00217646 [Public Redacted Version] Download
Jan 19, 2022 2138 patent_own Ex. 2138 - NOVITC(CH)00217650 [PUBLIC REDACTED VERSION] Download
Jan 19, 2022 2139 patent_own Ex. 2139 - NOVITC(CH)00810847 [PUBLIC REDACTED VERSION] Download
Jan 19, 2022 2140 patent_own Ex. 2140 - NOVITC(CH)00874056 [Public Redacted Version] Download
Jan 19, 2022 2141 patent_own Ex. 2141 - NOVITC(CH)00880433 [PUBLIC REDACTED VERSION] Download
Jan 19, 2022 2142 patent_own Ex. 2142 - NOVITC(CH)01494800 [PUBLIC REDACTED VERSION] Download
Jan 19, 2022 2143 patent_own Ex. 2143 - NOVITC(CH)01495912 [Public Redacted Version] Download
Jan 19, 2022 2144 patent_own Ex. 2144 - NOVITC(CH)01498292 [PUBLIC REDACTED VERSION] Download
Jan 19, 2022 2145 patent_own Ex. 2145 - NOVITC(CH)01863737 [Public Redacted Version] Download
Jan 19, 2022 2146 patent_own Ex. 2146 - NOVITC(CH)01863785 [PUBLIC REDACTED VERSION] Download
Jan 19, 2022 2147 patent_own Ex. 2147 - NOVITC(CH)01906307 [PUBLIC REDACTED VERSION] Download
Jan 19, 2022 2148 patent_own Ex. 2148 - NOVITC(CH)02022271 [Public Redacted Version] Download
Jan 19, 2022 2150 patent_own Ex. 2150 - NOVITC(CH)02929814 [Public Redacted Version] Download
Jan 19, 2022 2152 patent_own Ex. 2152 - NOVITC(US)00000788 [Public Redacted Version] Download
Jan 19, 2022 2153 patent_own Ex. 2153 - NOVITC(US)00000792 [Public Redacted Version] Download
Jan 19, 2022 2154 patent_own Ex. 2154 - NOVITC(US)00000795 [Public Redacted Version] Download
Jan 19, 2022 2155 patent_own Ex. 2155 - NOVITC(US)00006151 [Public Redacted Version] Download
Jan 19, 2022 2156 patent_own Ex. 2156 - NOVITC(US)00006173 [Public Redacted Version] Download
Jan 19, 2022 2157 patent_own Ex. 2157 - NOVITC(US)00006182 [Public Redacted Version] Download
Jan 19, 2022 2158 patent_own Ex. 2158 - NOVITC(US)00006196 [Public Redacted Version] Download
Jan 19, 2022 2159 patent_own Ex. 2159 - NOVITC(US)00006213 [Public Redacted Version] Download
Jan 18, 2022 2160 patent_own Ex. 2160 - Lucentis PFS Letter and Label Download
Jan 18, 2022 2161 patent_own Ex. 2161 - Roche Finance Report for 2016 Download
Jan 19, 2022 2161 patent_own Ex. 2161 - Roche Finance Report for 2016 Download
Jan 18, 2022 2162 patent_own Ex. 2162 - Roche Finance Report for 2014 Download
Jan 19, 2022 2162 patent_own Ex. 2162 - Roche Finance Report for 2014 Download
Jan 18, 2022 2163 patent_own Ex. 2163 - Roche Finance Report for 2019 Download
Jan 19, 2022 2163 patent_own Ex. 2163 - Roche Finance Report for 2019 Download
Jan 19, 2022 2164 patent_own Exhibit 2164 - Roche Finance Report 2013 Part 2 of 2 Download
Jan 19, 2022 2164 patent_own Ex. 2164 - Roche Finance Report 2013 Part 1 of 2 Download
Jan 19, 2022 2166 patent_own Ex. 2166 - NOVITC(US)00389194 [Public Redacted Version] Download
Jan 19, 2022 2167 patent_own Ex.. 2167 - NOVITC(US)00394737 [Public Redacted Version] Download
Jan 19, 2022 2168 patent_own Ex. 2168 - NOVITC(US)00395564 [Public Redacted Version] Download
Jan 19, 2022 2169 patent_own Ex. 2169 - NOVITC(US)00395565 [Public Redacted Version] Download
Jan 19, 2022 2170 patent_own Ex. 2170 - NOVITC(US)00507243 [Public Redacted Version] Download
Jan 19, 2022 2171 patent_own Ex. 2171 - NOVITC(US)00697489 [Public Redacted Version] Download
Jan 19, 2022 2172 patent_own Ex. 2172 - NOVITC(US)00718202 [Public Redacted Version] Download
Jan 18, 2022 2174 patent_own Ex. 2174 - WHO Guidelines on Packaging for Pharmaceutical Products Download
Jan 18, 2022 2175 patent_own Ex. 2175 - Akers 2010 Download
Jan 18, 2022 2176 patent_own Ex. 2176 - Boven 2005 Download
Jan 18, 2022 2177 patent_own Ex. 2177 - Tzannis 1996 Download
Jan 18, 2022 2178 patent_own Ex. 2178 - Markovic 2009 Download
Jan 18, 2022 2179 patent_own Ex. 2179 - Markovic 2011 Download
Jan 18, 2022 2180 patent_own Ex. 2180 - Silver 2008 Download
Jan 18, 2022 2181 patent_own Ex. 2181 - ISO-10993-1-2009 Download
Jan 18, 2022 2182 patent_own Ex. 2182 - Helmus 2008 Download
Jan 18, 2022 2183 patent_own Ex. 2183 - FDA Use of ISO-10993 Download
Jan 18, 2022 2184 patent_own Ex. 2184 - Rathore 2008 Download
Jan 19, 2022 2185 patent_own Ex. 2185 - Ansel 1995 Download
Jan 19, 2022 2186 patent_own Ex. 2186 - Lachman 1986 Download
Jan 19, 2022 2187 patent_own Ex. 2187 - ANSIAAMI ST67-2011 Download
Jan 19, 2022 2188 patent_own Ex. 2188 - ISO 14161 Download
Jan 18, 2022 2189 patent_own Ex. 2189 - Koller IPR Dep. Tr. Part 2 of 2 Download
Jan 18, 2022 2189 patent_own Ex. 2189 - Koller IPR Dep. Tr. Part 1 of 2 Download
Jan 19, 2022 2190 patent_own Ex. 2190 - Bash and Gould 1984 Download
Jan 19, 2022 2191 patent_own Ex. 2191 - CFR 2004 Download
Jan 19, 2022 2192 patent_own Ex. 2192 - CFR 2008 Download
Jan 19, 2022 2193 patent_own Ex. 2193 - CFR 2021 Download
Jan 19, 2022 2195 patent_own Ex. 2195 - Poche 2019 Download
Jan 19, 2022 2196 patent_own Ex. 2196 - ISO 10993-7-2008 Download
Jan 19, 2022 2197 patent_own Ex. 2197 - Eylea PFS Label Aug 2019 Download
Jan 18, 2022 2198 patent_own Ex. 2198 - Venook Declaration Download
Jan 18, 2022 2199 patent_own Ex. 2199 - ISO 11137 Download
Jan 18, 2022 2200 patent_own Ex. 2200 - Von Woedtke and Kramer Download
Jan 19, 2022 2201 patent_own Ex. 2201 - Supplemental Leinsing [Public Redacted Version] Download
Jan 18, 2022 2202 patent_own Ex. 2202 - Declaration of John E. Dillberger Download
Jan 19, 2022 2203 patent_own Ex. 2203 - Declaration of Michael J Miller [Public Redacted Version] Download
Jan 19, 2022 2204 patent_own Ex. 2204 - Calman Declaration [Public Redacted Version] Download
Jan 19, 2022 2205 patent_own Ex. 2205 - Malackowski Declaration [Public Redacted Version] Download
Jan 19, 2022 2206 patent_own Ex. 2206 - Declaration of Juergen Sigg [Public Redacted Version] Download
Jan 20, 2022 2208 patent_own Download
Jan 18, 2022 2209 patent_own Ex. 2209 - Wolfe Declaration Download
Jan 18, 2022 2210 patent_own Ex. 2210 - Curriculum Vitae of Dr. Kimberly Cameron Download
Jan 18, 2022 2211 patent_own Ex. 2211 - Curriculum Vitae of Dr. Jeremy Wolfe Download
Jan 18, 2022 2212 patent_own Ex. 2212 - Eylea Label 2021 Download
Jan 18, 2022 2213 patent_own Ex. 2213 - Lucentis Label 2017 Download
Jan 18, 2022 2214 patent_own Ex. 2214 - Chaturvedi Download
Jan 18, 2022 2215 patent_own Ex. 2215 - Storey et al. 2019 Download
Jan 18, 2022 2218 patent_own Ex. 2218 - Cilurzo Injectability Evaluation 2011 Download
Jan 18, 2022 2222 patent_own Ex. 2222 - Summary of EU Product Characteristics, Lucentis PFS Download
Jan 18, 2022 2224 patent_own Ex. 2224 - DSR5092D [PUBLIC REDACTED VERSION] Download
Jan 18, 2022 2227 patent_own Ex. 2227 - Application No. 13/750,352 Download
Jan 18, 2022 2228 patent_own Download
Jan 18, 2022 2229 patent_own Ex. 2229 - Rathore 2011 Download
Jan 18, 2022 2230 patent_own Ex. 2230 - EU Q5C Download
Jan 18, 2022 2231 patent_own Ex. 2231 - EYLEA Approval Letter Download
Jan 18, 2022 2232 patent_own Ex. 2232 - Freund 2006 Download
Jan 18, 2022 2253 patent_own Ex. 2253 - Jones 2005 Download
Jan 19, 2022 2254 patent_own Ex. 2254 - NOVITC(CH)00885630 [Public Redacted Version] Download
Jan 18, 2022 2255 patent_own Ex. 2255 - Teng 2012 Download
Jan 18, 2022 2256 patent_own Ex. 2256 - Calman CV Download
Jan 19, 2022 2257 patent_own Ex. 2257 - Kiss Depo Tr. Download
Jan 19, 2022 2258 patent_own Ex. 2258 - Macular Degeneration Treatments Download
Jan 19, 2022 2259 patent_own Ex. 2259 - Avastin Prescribing Information Part 4 of 4 Download
Jan 19, 2022 2259 patent_own Ex. 2259 - Avastin Prescribing Information Part 1 of 4 Download
Jan 19, 2022 2259 patent_own Ex. 2259 - Avastin Prescribing Information Part 3 of 4 Download
Jan 19, 2022 2259 patent_own Ex. 2259 - Avastin Prescribing Information Part 2 of 4 Download
Jan 19, 2022 2260 patent_own Ex. 2260 - Comparison of Anti VEGF Treatments Download
Jan 19, 2022 2261 patent_own Ex. 2261 - Age-Related Macular Degeneration Facts & Figures Download
Jan 19, 2022 2262 patent_own Ex. 2262 - FDA Approves Avastin Article Download
Jan 19, 2022 2264 patent_own Ex. 2264 - Roche March 22, 2018 Investor Update Download
Jan 19, 2022 2265 patent_own Ex. 2265 - Genentech, Inc. Form 10K for the period ending 12312003 Download
Jan 19, 2022 2266 patent_own Ex. 2266 - FDA Approves Lucentis Article Download
Jan 19, 2022 2269 patent_own Ex. 2269 - FDA Approves Eylea Article Download
Jan 19, 2022 2270 patent_own Ex. 2270 - FDA Approves Eylea PFS Article Download
Jan 19, 2022 2271 patent_own Ex. 2271 - Prefilled Syringe Delivery of Intravitreal Anti-VEGF Medications Download
Jan 19, 2022 2272 patent_own Ex. 2272 - Excerpted Chris Simms Transcript Download
Jan 19, 2022 2273 patent_own Ex. 2273 - Roche Finance Report for 2011 Download
Jan 19, 2022 2274 patent_own Ex. 2274 - Roche Finance Report for 2012 Part 2 of 2 Download
Jan 19, 2022 2274 patent_own Ex. 2274 - Roche Finance Report for 2012 Part 1 of 2 Download
Jan 19, 2022 2275 patent_own Ex. 2275 - Roche Finance Report for 2015 Part 2 of 2 Download
Jan 19, 2022 2275 patent_own Ex. 2275 - Roche Finance Report for 2015 Part 1 of 2 Download
Jan 19, 2022 2276 patent_own Ex. 2276 - Roche Finance Report for 2017 Part 3 of 3 Download
Jan 19, 2022 2276 patent_own Ex. 2276 - Roche Finance Report for 2017 Part 2 of 3 Download
Jan 19, 2022 2276 patent_own Ex. 2276 - Roche Finance Report for 2017 Part 1 of 3 Download
Jan 19, 2022 2277 patent_own Ex. 2277 - Treatments for Wet AMD Download
Jan 18, 2022 2278 patent_own Download
Jan 18, 2022 2279 patent_own Ex. 2279 - Macugen European Medicines Agency - EPAR website Download
Jan 18, 2022 2280 patent_own Ex. 2280 - Michaud 2014 Download
Jan 18, 2022 2281 patent_own Ex. 2281 - Krzystolik 2002 Download
Jan 18, 2022 2282 patent_own Ex. 2282 - FDA Approval for Macugen Download
Jan 18, 2022 2283 patent_own Ex. 2283 - FDA Approved Drugs Page for Macugen Download
Jan 18, 2022 2284 patent_own Ex. 2284 - Rich 2006 Download
Jan 18, 2022 2285 patent_own Ex. 2285 - Avastin FDA Label Download
Jan 18, 2022 2286 patent_own Ex. 2286 - Eylea FDA approval letter Download
Jan 18, 2022 2287 patent_own Ex. 2287 - Federman 1998 Download
Jan 18, 2022 2288 patent_own Ex. 2288 - Nguyen 1992 Download
Jan 18, 2022 2289 patent_own Ex. 2289 - Scott 2003 Download
Jan 18, 2022 2291 patent_own Ex. 2291 - Rosenberg 2006 Download
Jan 18, 2022 2292 patent_own Ex. 2292 - Charles 2009 Download
Jan 18, 2022 2293 patent_own Ex. 2293 - Stepien 2009 Download
Jan 18, 2022 2294 patent_own Ex. 2294 - Beovu approval letter Download
Jan 18, 2022 2295 patent_own Ex. 2295 - Mittra 2006 Download
Jan 18, 2022 2296 patent_own Ex. 2296 - Santaella 2007 Download
Jan 18, 2022 2297 patent_own Ex. 2297 - Abbasi 2009 Download
Jan 18, 2022 2298 patent_own Ex. 2298 - Schatz 1986 Download
Jan 18, 2022 2299 patent_own Ex. 2299 - Peck 2010 Download
Jan 19, 2022 2300 patent_own Ex. 2300 - Yoon 2009 Download
Jan 18, 2022 2301 patent_own Ex. 2301 - Lang 2007 Download
Jan 18, 2022 2302 patent_own Ex. 2302 - Chen 2013 Download
Jan 18, 2022 2303 patent_own Ex. 2303 - Sarao 2014 Download
Jan 18, 2022 2304 patent_own Ex. 2304 - Baudin 2018 Download
Jan 18, 2022 2305 patent_own Ex. 2305 - Wilson 2013 Download
Jan 18, 2022 2306 patent_own Ex. 2306 - Kamjoo 2021 Download
Jan 18, 2022 2307 patent_own Ex. 2307 - Jonas 2003 Download
Jan 18, 2022 2308 patent_own Ex. 2308 - Ramulu 2010 Download
Jan 18, 2022 2309 patent_own Ex. 2309 - Asbell 2016 Download
Jan 18, 2022 2310 patent_own Ex. 2310 - EVS Study Group 1995 Download
Jan 18, 2022 2311 patent_own Ex. 2311 - Dossarps 2015 Download
Jan 18, 2022 2312 patent_own Ex. 2312 - Klein 2009 Download
Jan 18, 2022 2313 patent_own Ex. 2313 - Green Simms 2011 Download
Jan 18, 2022 2314 patent_own Ex. 2314 - McCannell 2011 Download
Jan 18, 2022 2315 patent_own Ex. 2315 - Shimada 2013 Download
Jan 18, 2022 2316 patent_own Ex. 2316 - Levinson 2018 Download
Jan 18, 2022 2317 patent_own Ex. 2317 - Gallemore 2006 Download
Jan 18, 2022 2318 patent_own Ex. 2318 - Ip 2004 Download
Jan 18, 2022 2319 patent_own Ex. 2319 - Gedde 2006 Download
Jan 18, 2022 2320 patent_own Ex. 2320 - Riedel 1990 Download
Jan 18, 2022 2321 patent_own Ex. 2321 - Thompson 2021 Download
Jan 18, 2022 2322 patent_own Ex. 2322 - Kahook 2010 Download
Jan 18, 2022 2323 patent_own Ex. 2323 - Second Modified Protective Order Download
Jan 18, 2022 2324 patent_own Ex. 2324 - Redline of Second Modified Protective Order Download
Jan 18, 2022 2325 patent_own Ex. 2325 - Declaration of Martina Athanas Download
Jan 18, 2022 2326 patent_own Ex. 2326 - FDA Eylea PFS Approval Letter Download
Mar 3, 2022 2330 patent_own Ex. 2330 - Order appointing Swiss Commissioners, International Trade Commission Inv. No. 337-1207, Certain Pre-Filled Syringes for Intravitreal Injection and Components Thereof Download
Mar 3, 2022 2331 patent_own Ex. 2331 - Order appointing Swiss Commissioners, Novartis Pharma AG et al v. Regeneron Pharmaceuticals, Inc., No. 1:20-cv00690-DH-CFH (NDNY) Download
Mar 3, 2022 2332 patent_own Ex. 2332 - Proposed Order Appointing Commissioners Download
Mar 24, 2022 2333 patent_own Download
Mar 24, 2022 2334 patent_own Ex. 2334 - Declaration of Daniel P. Margolis in Support of Patent Owners Motion for Pro Hac Vice Admission of Daniel P. Margolis Under 37 C.F.R. 42.10 (c) Download
May 11, 2022 2335 patent_own Akers and Agalloco 2013, Overcoming Limitations of Vaporized Hydrogen Peroxide Download
May 11, 2022 2336 patent_own Agalloco 2008, Chapter in Pharmaceutical Manufacturing Handbook Download
May 26, 2022 2339 patent_own Deposition Transcript of James Agalloco (May 4, 2022) [Redacted Version] Download
May 26, 2022 2340 patent_own Deposition Transcript of Joel M. Cohen (May 19, 2022) Download
May 26, 2022 2345 patent_own Deposition Transcript of Szilard Kiss, M.D., Vol. 2 (May 13, 2022) [Redacted Version] Download
May 26, 2022 2347 patent_own Deposition Transcript of Horst Koller, Vol. 2 (May 16, 2022) [Redacted Version] Download
Aug 27, 2021 3001 board E-Mail Download
May 25, 2022 3002 board Exhibit 3002 Download
Menu